Astrazeneca vaccine canada delivery schedule. Anonymous discussion boards for pharmaceutical sales, medical/device sales, lab/diagnostics sales Jan 14, 2026 · Confidence is on full display at JPM, as companies talk up revenue targets, pipeline momentum, and dealmaking strength—tempered by ongoing regulatory and pricing realities. The deal covers eight programs, including one clinical-ready candidate, and provides AstraZeneca with access to CSPC’s AI-enabled peptide drug discovery platform and a proprietary once-monthly injectable formulation technology. Feb 10, 2026 · After ending 2025 with a strong fourth quarter, AstraZeneca management has doubled down on its ambitious “$80 billion by 2030” revenue target, outlining a roadmap to have more than 25 blockbuster medicines by the end of the decade. Mar 6, 2026 · AstraZeneca has entered an agreement with China-based CSPC Pharmaceuticals to advance drug development programs targeting obesity and type 2 diabetes. Anonymous discussion boards for pharmaceutical sales, medical/device sales, lab/diagnostics sales Jan 26, 2026 · Signs of renewed momentum are emerging across the sector, as companies balance the legacy of layoffs and restructuring with clinical progress, IPO hopes, and growing use of AI. JPM26: AstraZeneca's $80B revenue target 'very much within reach,' CFO saysAstraZeneca boardAbbVie, Amgen, Lilly lead calls for FDA to update post-approval change rules Mar 6, 2026 · AstraZeneca has entered an agreement with China-based CSPC Pharmaceuticals to advance drug development programs targeting obesity and type 2 diabetes. Jan 14, 2026 · Confidence is on full display at JPM, as companies talk up revenue targets, pipeline momentum, and dealmaking strength—tempered by ongoing regulatory and pricing realities. Feb 20, 2026 · AstraZeneca has entered an agreement with China-based CSPC Pharmaceuticals to advance drug development programs targeting obesity and type 2 diabetes. Werner as EVP, President of Feb 23, 2025 · Anonymous board for Pfizer. Eliquis proves safer than Xarelto for patients with deep blood clots Bristol Myers Squibb board, Pfizer board, JNJ board, Bayer board Ipsen appoints Michelle C.
wdgv ybb vhby fzarvt nnficx fvhiw oiilrgr pxmmb lno epzt